NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its third quarter revenues rose 74 percent year over year, thanks largely to a 105 percent increase in testing services revenues.

For the three months ended Sept. 30, the diagnostics company said revenues rose to $21.2 million from $12.2 million in Q3 2017, beating analysts' average estimate of $18.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.